Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals | 8 | 0 | 1 | 0 | €4.12 | €10.96 | 165.916% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.11 | €13.74 | 1136.922% |
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €38.20 | €51.20 | 34.025% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €10.20 | €27.03 | 165.010% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €365.20 | €421.61 | 15.445% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €3.50 | €5.76 | 64.469% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.00 | €23.46 | 67.599% |
| Sanofi S.A. ADR | 11 | 0 | 0 | 0 | €46.20 | - | - |
| Teva Pharmaceutical Industries Ltd ADR | 11 | 0 | 0 | 0 | €13.00 | €13.50 | 3.846% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €22.80 | €35.43 | 55.392% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
| Exact Sciences | 11 | 0 | 0 | 0 | €57.68 | €83.49 | 44.755% |
| Prothena Corp. plc | 12 | 0 | 1 | 0 | €21.40 | €81.43 | 280.523% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €18.26 | €38.19 | 109.223% |
| Incyte Corp. | 12 | 2 | 3 | 1 | €49.94 | €78.42 | 57.033% |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.65 | €4.63 | 26.838% |
| Intellia Therapeutics Inc | 12 | 0 | 0 | 0 | €21.91 | €60.13 | 174.418% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| Insmed Inc. | 13 | 1 | 2 | 1 | €23.80 | €44.01 | 84.902% |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.94 | €8.39 | 332.948% |
| Halozyme Therapeutics Inc. | 13 | 0 | 2 | 0 | €37.15 | €53.50 | 43.998% |
| Stoke Therapeutics Inc | 13 | 1 | 1 | 0 | €11.20 | €21.00 | 87.532% |